Fig. 8: Long-term observation of skin metagenes and blood cytokines in dupilumab-treated patients.

A Dynamics of skin metagene expression and blood cytokines in individual patients during the long-term course of dupilumab treatment. Green highlighted shadows represent the 95% CI for the mean expression in healthy individuals. B Transition in relative values compared with the baseline skin metagene expression and blood cytokines in four poorly responding patients. C Clinical images of the four poorly responding patients before and after treatment. No apparent changes in clinical phenotypes were observed during the course of treatment.